FDA’s PMTA denials get a warm political welcome – but not the delay over Juul

The US Food and Drug Administration (FDA)’s denial of premarket tobacco product applications (PMTAs) has been mostly welcomed by politicians and public health organisations some of whom have urged the agency to deny Juul Labs’ application too.

US senator Dick Durbin of Illinois said he was glad to hear that the federal agency had rejected most of the applications but said it was “unacceptable” that the evaluation of Juul products had been postponed.

Read full article
I'm already a subscriber
Author default picture

David Palacios Rubio

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization